National Vaccine And Serum Institute, China

This study is testing a new HPV vaccine to see if a simpler 2-dose schedule for younger girls (9-14 years) works as well as the standard 3-dose schedule for older teens and young women (9-35 years). It will enroll 1,800 female participants to compare the strength and durability o…